Recent research has unveiled intriguing connections between genetic variations and the effectiveness of weight-loss medications like Wegovy and Mounjaro. The study, published in the esteemed journal Nature, highlights how certain genetic factors can influence the degree of weight loss achieved by individuals, as well as the likelihood of experiencing adverse side effects. This discovery could have significant implications for the treatment of obesity, especially as more people turn to these medications.
Genetic Variants and Weight Loss
The study analysed data from 15,000 individuals who had previously undergone genetic testing by 23andMe, revealing that those with specific variations in two genes related to appetite and digestion tended to shed more pounds when using weight-loss drugs. On average, participants lost approximately 11.7% of their body weight over an eight-month treatment period, with some achieving as much as a 30% reduction in their overall weight.
Professor Ruth Loos from the University of Copenhagen, who contributed to the research, noted that one genetic variant linked to weight loss also correlated with increased instances of nausea. Those who carry this variant lost an average of 0.76 kg (1.6 lbs) more than their peers. Interestingly, individuals with two copies of this gene variant could potentially double their weight loss. The prevalence of this variant appears to be notably higher among those of European descent, with 64% possessing one copy compared to only 7% of African Americans.
Side Effects and Variability in Response
While the genetic predisposition to weight loss is a crucial factor, the study also identified another variant associated with severe side effects, such as nausea and vomiting, particularly in those taking Mounjaro. This could mean that approximately 1% of users may experience extreme vomiting—nearly 15 times more severe than typical side effects. Despite the genetic influence, Professor Loos emphasised that genetics plays a modest role in the broader context of weight loss, which is influenced by a multitude of factors including age, sex, and ethnicity.
Dr Marie Spreckley from the University of Cambridge echoed this sentiment, stating that genetics is merely one piece of a complex puzzle. She pointed out that behavioural factors, including daily exercise and dietary habits, as well as the support systems in place for those using these medications, significantly affect outcomes. Previous research highlighted that women are over twice as likely to achieve a 15% weight loss on Mounjaro compared to men, suggesting that gender also plays a role in treatment efficacy.
Implications for Precision Medicine
As the landscape of obesity treatment evolves, the potential for “precision medicine” becomes increasingly relevant. By integrating genetic information with other individual health factors, practitioners could tailor weight-loss strategies to enhance effectiveness and minimise adverse effects. However, experts caution that more extensive clinical trials are necessary to validate these findings before they can be routinely applied in medical practice.
Professor Naveed Sattar, a metabolic health expert at the University of Glasgow, emphasised the need for further robust trial data to understand the balance of benefits and drawbacks associated with these emerging therapies. He remarked that while the current findings are scientifically fascinating, they are still a considerable distance from altering clinical guidelines.
Why it Matters
The implications of this research extend far beyond individual weight loss. Understanding the genetic factors that influence treatment outcomes could pave the way for more effective obesity management strategies. As millions turn to weight-loss medications in the UK and globally, recognising the interplay between genetics, behaviour, and treatment can lead to more personalised healthcare solutions. Ultimately, this could transform how we approach obesity—a condition that impacts countless lives—by ensuring that individuals receive tailored treatments that maximise their chances of success while minimising unwanted side effects.
